Author Details :
Volume : 2, Issue : 2, Year : 2016
Article Page : 46-50
Background: Peritoneal dialysis (PD) is the main stream of treatment as renal replacement therapy in pediatric patients with AKI in developing countries. Acute kidney injury (AKI) is a well-recognized complication of severe malaria in adults, but its incidence, prevalence and clinical importance in paediatric medicine not well documented.
Objectives: To find out the effect of peritoneal dialysis on outcome of malarial AKI children in a tertiary care centre.
Methods: A cross-sectionaldone in under 14 children suffering from severe malaria (SM). Neonates, children with associated pre-existing renal disease or having chronic kidney disease (CKD) or acute on CKD and known hypertensives were excluded. All the enrolled children were screen for AKI as per KDIGO guidelines & categorised in two three stages. PD was done as per the predefined criteria& all relevant data were analysed with computer generated software.
Results: Out of 406 SM cases, AKI detected in 15% with female predominance Mortality among renal failure patients is 26.67%. PD required in 52.0% of patients & mortality rate of 25.0% in KDIGO stage I, II but 55.0% in KDIGO Stage III significance(p=0.000). There is a significant correlation between pre dialysis & post dialysis serum urea/ creatinine/ potassium/ TPC & urine output (p = 0.000).
Conclusion: AKI is an under-recognized complication in young kids with SM and is related to enhanced acute/ long-term morbidity & mortality. Its early detection & intervention by peritoneal dialysis improves the same.
Keywords: Severe malaria (SM), Acute Kidney Injury (AKI), Peritoneal dialysis(PD), KDIGO(Kidney Disease: Improving Global Outcome) guidelines, Chronic, Kidney Disease(CKD)
How to cite : Mishra N R, Panda P C, Nayak S R, Effect of peritoneal dialysis on malarial AKI children: a cross sectional study. IP Int J Med Paediatr Oncol 2016;2(2):46-50
Copyright © 2016 by author(s) and IP Int J Med Paediatr Oncol. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (creativecommons.org)